| Literature DB >> 28808842 |
Luca Antonioli1,2, Carolina Pellegrini1, Matteo Fornai3, Erika Tirotta1, Daniela Gentile1, Laura Benvenuti1, Maria Cecilia Giron4, Valentina Caputi4,5, Ilaria Marsilio4, Genny Orso6, Nunzia Bernardini1, Cristina Segnani1, Chiara Ippolito1, Balázs Csóka2, Zoltán H Németh7, György Haskó2, Carmelo Scarpignato8, Corrado Blandizzi1, Rocchina Colucci4.
Abstract
Adenosine A2B receptors (A2BR) regulate several enteric functions. However, their implication in the pathophysiology of intestinal dysmotility associated with high-fat diet (HFD)-induced obesity has not been elucidated. We investigated the expression of A2BR in mouse colon and their role in the mechanisms underlying the development of enteric dysmotility associated with obesity. Wild-type C57BL/6J mice were fed with HFD (60% kcal from fat) or normocaloric diet (NCD; 18% kcal from fat) for 8 weeks. Colonic A2BR localization was examined by immunofluorescence. The role of A2BR in the control of colonic motility was examined in functional experiments on longitudinal muscle preparations (LMPs). In NCD mice, A2BR were predominantly located in myenteric neurons; in HFD animals, their expression increased throughout the neuromuscular layer. Functionally, the A2BR antagonist MRS1754 enhanced electrically induced NK1-mediated tachykininergic contractions in LMPs from HFD mice, while it was less effective in tissues from NCD mice. The A2B receptor agonist BAY 60-6583 decreased colonic tachykininergic contractions in LMPs, with higher efficacy in preparations from obese mice. Both A2BR ligands did not affect contractions elicited by exogenous substance P. Obesity is related with a condition of colonic inflammation, leading to an increase of A2BR expression. A2BR, modulating the activity of excitatory tachykininergic nerves, participate to the enteric dysmotility associated with obesity.Entities:
Keywords: A2B receptors; Colonic motor dysfunctions; Obesity; Substance P
Mesh:
Substances:
Year: 2017 PMID: 28808842 PMCID: PMC5714840 DOI: 10.1007/s11302-017-9577-0
Source DB: PubMed Journal: Purinergic Signal ISSN: 1573-9538 Impact factor: 3.765